II. Pathophysiology
- Chronic inflammatory disease of the Esophagus ("Asthma of the Esophagus")
- IgE Immune-mediated Esophagitis
III. Symptoms: Teens and Adults
- Solid Dysphagia
- Food impaction (associated with Esophageal Strictures in up to 31%)
- Central Chest Pain refractory to Antacids
- Refractory GERD
- Upper abdominal (Epigastric Pain)
IV. Symptoms: Younger Children
- Feeding dysfunction
- Vomiting
- Abdominal Pain
V. Associated Conditions: Allergic Disorders
- Asthma
- Atopic Dermatitis
- Food Allergies
- Gluten Sensitive Enteropathy
- Environmental Allergies
VI. Diagnosis
- Upper Endoscopy with biopsy
- Esophageal Trachealization
- Concentric rings within Esophagus
- Esophageal biopsy
- Superficial mucosa with Eosinophil infiltration
- Esophageal Trachealization
- Factors more suggestive of Eosinophilc Esophagitis (in contrast to GERD)
- Younger age
- Male gender
- Dysphagia
- Food allergies
- Esophageal Rings, furrows or Plaques on endoscopy
- Hiatal Hernia absent
VII. Differential Diagnosis
- See Vomiting
- Gastroesophageal Reflux Disease
- Esophageal Dysmotility
- Inflammatory Bowel Disease
- Esophageal Cancer
- Parasitic Infection
- Other Esophagitis (e.g. candidal Esophagitis)
VIII. Management
- Manage as Gastroesophageal Reflux disease initially (prior to diagnosis by endoscopy and biopsy)
- Proton Pump Inhibitor (high dose, e.g. Omeprazole 40 mg orally twice daily)
- GERD precautions (avoiding Alcohol, Tobacco, Caffeine, food within 2 hours of lying supine)
- Avoid possible food triggers
- Identify and avoid triggering food (e.g. milk, wheat, eggs, soy, nuts and seafood)
- See Elimination Diet
- Risk of Vitamin Deficiency if restrictive diet
- Triggering food elimination results in up to 40% remission
- Formal Food Allergy testing is not recommended
- Identify and avoid triggering food (e.g. milk, wheat, eggs, soy, nuts and seafood)
-
Inhaled Corticosteroids (e.g. Flovent HFA, budesonide) swallowed instead of inhaled
- Use Metered Dose Inhalers (not Dry Powder Inhalers)
- Puff the Inhaler within the mouth without inspiring, and then swallow the medication
- Alternatively, may mix budesonide nebules with Splenda and swallow
- Rinse mouth of steroid, but do not swallow water, other liquid or solid for at least 30 minutes
- Risk of Oral Candidiasis
- Alternative agents
- Budesonide Oral Suspension (Eohilia) is $2000/month in 2025
- Budesonide inhalation suspension 2 mg/dose
- Compound as home in honey or maple syrup (10 ml total) swallowed
-
Biologic Agents
- Interleukin-4 Alpha Receptor Antagonist: Dupilumab (Dupixent)
- FDA approved down to 1 year in refractory Eosinophilic Esophagitis
- Interleukin-4 Alpha Receptor Antagonist: Dupilumab (Dupixent)
- Maintenance
- Continue maintenance therapy indefinitely (if not resolved with food trigger avoidance)
- Expect flares to recur at 3 months after stopping maintenance therapy
- Endoscopy
- Endoscopy performed at routine intervals
- Espohageal Biopsy is typically obtained at 8 to 12 weeks after starting treatment to assess response
- Continue maintenance therapy indefinitely (if not resolved with food trigger avoidance)
IX. Complications
X. References
- Bonis and Furuta (2017) ...Eosinophilic Esophagitis, UpToDate, Wolters Kluwer, accessed 11/4/2017
- (2017) Presc Lett 24(11): 65
- (2025) Presc Lett 32(4): 23